Dr. Mascitti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
701 Ostrum Street
Suite 103
Bethlehem, PA 18015Phone+1 484-526-6200Fax+1 833-222-9421
Education & Training
University of Pennsylvania Health SystemFellowship, Infectious Disease, 2006 - 2008- University of Pennsylvania Health SystemResidency, Internal Medicine, 2003 - 2006
Duke University School of MedicineClass of 2003
Certifications & Licensure
NJ State Medical License 2017 - 2025
PA State Medical License 2003 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 3 citationsDerivation and validation of clinical prediction rules for reduced vancomycin susceptibility in Staphylococcus aureus bacteraemiaJennifer H. Han, Warren B. Bilker, Paul H. Edelstein, Kara B. Mascitti, Ebbing Lautenbach
Epidemiology and Infection. 2013-01-01 - 21 citationsEffect of Reduced Vancomycin Susceptibility on Clinical and Economic Outcomes in Staphylococcus aureus BacteremiaJennifer H. Han, Kara B. Mascitti, Paul H. Edelstein, Warren B. Bilker, Ebbing Lautenbach
Antimicrobial Agents and Chemotherapy. 2012-10-01 - 8 citationsPrior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia.Kara B. Mascitti, Paul H. Edelstein, Neil O. Fishman, Knashawn H. Morales, Andrew J. Baltus
Infection Control and Hospital Epidemiology. 2012-02-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
